YD Biopharma Limited

Breeze Holdings Acquisition Corp. (Nasdaq: BRZH), sponsored by Breeze Sponsor LLC and originally targeting the energy and oil and gas sector when it completed its IPO in 2020, announced a business combination with YD Biopharma Limited in September 2024, marking a notable sector pivot toward the biopharmaceutical industry. The transaction subsequently closed, making YD Biopharma a publicly listed company through the SPAC vehicle. The deal is among several in recent SPAC history where the completed merger diverged from the blank-check company's originally stated industry focus. For full deal terms, filing history, shareholder vote results, and post-close performance data on BRZH and thousands of other SPAC transactions, sign up for SpacDesk at spacdesk.com.

SPAC Counterparty (1)